Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Gastroenterology ; 148(5): 1012-1023.e14, 2015 May.
Artículo en Inglés | MEDLINE | ID: mdl-25701738

RESUMEN

BACKGROUND & AIMS: Hyperhomocysteinemia is often associated with liver and metabolic diseases. We studied nuclear receptors that mediate oscillatory control of homocysteine homeostasis in mice. METHODS: We studied mice with disruptions in Nr0b2 (called small heterodimer partner [SHP]-null mice), betaine-homocysteine S-methyltransferase (Bhmt), or both genes (BHMT-null/SHP-null mice), along with mice with wild-type copies of these genes (controls). Hyperhomocysteinemia was induced by feeding mice alcohol (National Institute on Alcohol Abuse and Alcoholism binge model) or chow diets along with water containing 0.18% DL-homocysteine. Some mice were placed on diets containing cholic acid (1%) or cholestyramine (2%) or high-fat diets (60%). Serum and livers were collected during a 24-hour light-dark cycle and analyzed by RNA-seq, metabolomic, and quantitative polymerase chain reaction, immunoblot, and chromatin immunoprecipitation assays. RESULTS: SHP-null mice had altered timing in expression of genes that regulate homocysteine metabolism compared with control mice. Oscillatory production of S-adenosylmethionine, betaine, choline, phosphocholine, glyceophosphocholine, cystathionine, cysteine, hydrogen sulfide, glutathione disulfide, and glutathione, differed between SHP-null mice and control mice. SHP inhibited transcriptional activation of Bhmt and cystathionine γ-lyase by FOXA1. Expression of Bhmt and cystathionine γ-lyase was decreased when mice were fed cholic acid but increased when they were placed on diets containing cholestyramine or high-fat content. Diets containing ethanol or homocysteine induced hyperhomocysteinemia and glucose intolerance in control, but not SHP-null, mice. In BHMT-null and BHMT-null/SHP-null mice fed a control liquid, lipid vacuoles were observed in livers. Ethanol feeding induced accumulation of macrovesicular lipid vacuoles to the greatest extent in BHMT-null and BHMT-null/SHP-null mice. CONCLUSIONS: Disruption of Shp in mice alters timing of expression of genes that regulate homocysteine metabolism and the liver responses to ethanol and homocysteine. SHP inhibits the transcriptional activation of Bhmt and cystathionine γ-lyase by FOXA1.


Asunto(s)
Ritmo Circadiano , Factor Nuclear 3-alfa del Hepatocito/metabolismo , Homocisteína/metabolismo , Hiperhomocisteinemia/metabolismo , Hígado/metabolismo , Receptores Citoplasmáticos y Nucleares/metabolismo , Animales , Betaína-Homocisteína S-Metiltransferasa/genética , Betaína-Homocisteína S-Metiltransferasa/metabolismo , Glucemia/metabolismo , Resina de Colestiramina , Ácido Cólico , Cistationina gamma-Liasa/genética , Cistationina gamma-Liasa/metabolismo , Dieta Alta en Grasa , Modelos Animales de Enfermedad , Etanol , Regulación Enzimológica de la Expresión Génica , Intolerancia a la Glucosa/sangre , Intolerancia a la Glucosa/metabolismo , Homeostasis , Homocisteína/sangre , Hiperhomocisteinemia/sangre , Hiperhomocisteinemia/inducido químicamente , Hiperhomocisteinemia/genética , Hiperhomocisteinemia/prevención & control , Ratones Noqueados , ARN Mensajero/metabolismo , Receptores Citoplasmáticos y Nucleares/deficiencia , Receptores Citoplasmáticos y Nucleares/genética , Factores de Tiempo , Activación Transcripcional
2.
Mol Pharm ; 7(1): 105-15, 2010 Feb 01.
Artículo en Inglés | MEDLINE | ID: mdl-19968324

RESUMEN

Despite remarkable progress in the research of both viral and nonviral gene delivery vectors, the drawbacks in each delivery system have limited their clinical applications. Therefore, one of the concepts for developing novel vectors is to overcome the limitations of individual vectors by combining them. In the current study, adenoviral vectors were formulated with anionic liposomes to protect them from neutralizing antibodies and to improve their transduction efficiency in Coxsackievirus-adenovirus receptor (CAR) deficient cells. A calcium-induced phase change method was applied to encapsulate adenovirus 5 (Ad5) into anionic liposomes to formulate the complexes of Ad5 and anionic liposomes (Ad5-AL). Meanwhile, the complexes of Ad5 and cationic liposomes (Ad5-CL) were also prepared as controls. LacZ gene expression in CAR overexpressing cells (A549) and CAR deficient cells (CHO and MDCK) was measured by either qualitative or quantitative detection. Confocal laser scanning microscopy was performed to determine intracellular location of Ad5 after their infection. Human sera with a high titer of antiadenovirus antibody were used to assess the neutralizing antibody protection ability of the complexed vectors. Accompanying the enhanced gene expression, a high ability to introduce Ad5 into cytoplasm and nucleus mediated by Ad5-AL was also observed in CAR deficient cells. Additionally, antibody neutralizing assay indicated that neutralizing serum inhibited naked Ad5 and Ad5-CL at rather higher dilution than Ad5-AL, which demonstrated Ad5-AL was more capable of protecting Ad5 from neutralizing than Ad5-CL. In conclusion, anionic liposomes prepared by the calcium-induced phase change method could significantly enhance the transduction ability of Ad5 in CAR deficient cells.


Asunto(s)
Adenovirus Humanos/genética , Técnicas de Transferencia de Gen , Receptores Citoplasmáticos y Nucleares/deficiencia , Adenovirus Humanos/ultraestructura , Animales , Aniones , Secuencia de Bases , Células CHO , Línea Celular , Receptor de Androstano Constitutivo , Cricetinae , Cricetulus , Cartilla de ADN/genética , Perros , Expresión Génica , Genes Reporteros , Humanos , Operón Lac , Liposomas/química , Microscopía Confocal , Microscopía Electrónica de Transmisión , Pruebas de Neutralización , Receptores Citoplasmáticos y Nucleares/genética , Transducción Genética
3.
J Cell Biol ; 156(3): 481-94, 2002 Feb 04.
Artículo en Inglés | MEDLINE | ID: mdl-11815635

RESUMEN

Five isoforms of acyl-CoA oxidase (Aox), designated Aox1p to Aox5p, constitute a 443-kD heteropentameric complex containing one polypeptide chain of each isoform within the peroxisomal matrix of the yeast Yarrowia lipolytica. Assembly of the Aox complex occurs in the cytosol and precedes its import into peroxisomes. Peroxisomal targeting of the Aox complex is abolished in a mutant lacking the peroxin Pex5p, a component of the matrix protein targeting machinery. Import of the Aox complex into peroxisomes does not involve the cytosolic chaperone Pex20p, which mediates the oligomerization and import of peroxisomal thiolase. Aox2p and Aox3p play a pivotal role in the formation of the Aox complex in the cytosol and can substitute for one another in promoting assembly of the complex. In vitro, these subunits retard disassembly of the Aox complex and increase the efficiency of its reassembly. Neither Aox2p nor Aox3p is required for acquisition of the cofactor FAD by other components of the complex. We provide evidence that the Aox2p- and Aox3p-assisted assembly of the Aox complex in the cytosol is mandatory for its import into peroxisomes and that no component of the complex can penetrate the peroxisomal matrix as a monomer.


Asunto(s)
Acilcoenzima A/metabolismo , Peroxisomas/enzimología , Polímeros/metabolismo , Pliegue de Proteína , Transporte de Proteínas/fisiología , Yarrowia/enzimología , Acilcoenzima A/efectos de los fármacos , Citosol/efectos de los fármacos , Citosol/metabolismo , Flavina-Adenina Dinucleótido/metabolismo , Guanidina/farmacología , Mutación/fisiología , Parasimpaticomiméticos/farmacología , Receptor de la Señal 1 de Direccionamiento al Peroxisoma , Peroxisomas/efectos de los fármacos , Isoformas de Proteínas/efectos de los fármacos , Isoformas de Proteínas/metabolismo , Transporte de Proteínas/efectos de los fármacos , Receptores Citoplasmáticos y Nucleares/deficiencia , Receptores Citoplasmáticos y Nucleares/genética , Yarrowia/citología , Yarrowia/efectos de los fármacos
4.
Exp Mol Med ; 40(4): 427-34, 2008 Aug 31.
Artículo en Inglés | MEDLINE | ID: mdl-18779655

RESUMEN

Use of adenoviruses as vehicle for gene therapy requires that target cells express appropriate receptors such as coxsakievirus and adenovirus receptor (CAR). We show here that CAR-deficiency in cancer cells, that limits adenoviral gene delivery, can be overcome by using adenovirus complexed with the liposome, Ad-PEGPE [1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(poly-ethylene glycol)-2000]. We first confirmed that CT-26 mouse colon cancer cells are deficient in CAR by RT-PCR, and then showed that CT-26 cells infected with Ad-GFP/PEGPE exhibited highly enhanced expression of green fluorescent protein (GFP), compared with those infected with Ad-GFP. GFP expression depends on the dose of liposome and adenovirus. Luciferase expression in livers treated with Ad-luc/PEGPE was about 1,000-fold less than those infected with Ad-luc. In a liver metastasis mouse tumor model developed by intrasplenic injection of CT-26 cells, luciferase expression following i.v. injection of Ad-luc/PEGPE was significantly higher in tumors than in adjacent non-neoplastic liver. Following systemic administration of Ad-GFP/PEGPE, GFP expression increased in tumors more than in adjacent liver while the reverse was true following administration of Ad-GFP. In the latter case, GFP expression was higher in liver than in tumors. This study demonstrates that systemic delivery of PEGPE-adenovirus complex is an effective tool of adenoviral delivery as it overcomes limitation due to CAR deficiency of target cells while reducing hepatic uptake and enhancing adenoviral gene expression in tumors.


Asunto(s)
Adenoviridae , Neoplasias del Colon/genética , Neoplasias del Colon/terapia , Técnicas de Transferencia de Gen , Liposomas/uso terapéutico , Receptores Virales/genética , Adenoviridae/genética , Adenoviridae/metabolismo , Animales , Neoplasias del Colon/metabolismo , Neoplasias del Colon/patología , Receptor de Androstano Constitutivo , Relación Dosis-Respuesta a Droga , Terapia Genética , Vectores Genéticos , Proteínas Fluorescentes Verdes/genética , Liposomas/administración & dosificación , Liposomas/química , Liposomas/farmacocinética , Hígado/efectos de los fármacos , Hígado/metabolismo , Masculino , Ratones , Ratones Endogámicos BALB C , Ratones Transgénicos , Células 3T3 NIH , Fosfatidiletanolaminas/administración & dosificación , Fosfatidiletanolaminas/química , Fosfatidiletanolaminas/farmacocinética , Fosfatidiletanolaminas/uso terapéutico , Polietilenglicoles/administración & dosificación , Polietilenglicoles/química , Polietilenglicoles/farmacocinética , Polietilenglicoles/uso terapéutico , Receptores Citoplasmáticos y Nucleares/deficiencia , Receptores Citoplasmáticos y Nucleares/genética , Receptores Virales/deficiencia , Factores de Transcripción/deficiencia , Factores de Transcripción/genética , Células Tumorales Cultivadas
5.
Circulation ; 108(19): 2393-9, 2003 Nov 11.
Artículo en Inglés | MEDLINE | ID: mdl-14557369

RESUMEN

BACKGROUND: Peroxisome proliferator-activated receptor-alpha (PPAR-alpha) is expressed in the heart and regulates genes involved in myocardial fatty acid oxidation (FAO). The role of PPAR-alpha in acute ischemia/reperfusion myocardial injury remains unclear. METHODS AND RESULTS: The coronary arteries of male mice were ligated for 30 minutes. After reperfusion for 24 hours, ischemic and infarct sizes were determined. A highly selective and potent PPAR-alpha agonist, GW7647, was administered by mouth for 2 days, and the third dose was given 1 hour before ischemia. GW7647 at 1 and 3 mg x kg(-1) x d(-1) reduced infarct size by 28% and 35%, respectively (P<0.01), and myocardial contractile dysfunction was also improved. Cardioprotection by GW7647 was completely abolished in PPAR-alpha-null mice. Ischemia/reperfusion downregulated mRNA expression of cardiac PPAR-alpha and FAO enzyme genes, decreased myocardial FAO enzyme activity and in vivo cardiac fat oxidation, and increased serum levels of free fatty acids. All of these changes were reversed by GW7647. Moreover, GW7647 attenuated ischemia/reperfusion-induced release of multiple proinflammatory cytokines and inhibited neutrophil accumulation and myocardial expression of matrix metalloproteinases-9 and -2. Furthermore, GW7647 inhibited nuclear factor-kappaB activation in the heart, accompanied by enhanced levels of inhibitor-kappaBalpha. CONCLUSIONS: Activation of PPAR-alpha protected the heart from reperfusion injury. This cardioprotection might be mediated through metabolic and antiinflammatory mechanisms. This novel effect of the PPAR-alpha agonist could provide an added benefit to patients treated with PPAR-alpha activators for dyslipidemia.


Asunto(s)
Butiratos/uso terapéutico , Isquemia Miocárdica/tratamiento farmacológico , Daño por Reperfusión Miocárdica/prevención & control , Compuestos de Fenilurea/uso terapéutico , Receptores Citoplasmáticos y Nucleares/agonistas , Factores de Transcripción/agonistas , Animales , Butiratos/administración & dosificación , Quimiotaxis de Leucocito/efectos de los fármacos , Citocinas/metabolismo , Regulación hacia Abajo/efectos de los fármacos , Evaluación Preclínica de Medicamentos , Ácidos Grasos/sangre , Proteínas I-kappa B/biosíntesis , Ligadura , Masculino , Metaloproteinasas de la Matriz/biosíntesis , Ratones , Ratones Noqueados , Infarto del Miocardio/tratamiento farmacológico , Infarto del Miocardio/patología , Isquemia Miocárdica/patología , Daño por Reperfusión Miocárdica/patología , Miocardio/enzimología , Inhibidor NF-kappaB alfa , FN-kappa B/antagonistas & inhibidores , Oxidación-Reducción , Compuestos de Fenilurea/administración & dosificación , Premedicación , ARN Mensajero/biosíntesis , Receptores Citoplasmáticos y Nucleares/deficiencia , Receptores Citoplasmáticos y Nucleares/genética , Receptores Citoplasmáticos y Nucleares/fisiología , Factores de Transcripción/deficiencia , Factores de Transcripción/genética , Factores de Transcripción/fisiología
6.
PLoS One ; 6(2): e16683, 2011 Feb 08.
Artículo en Inglés | MEDLINE | ID: mdl-21346810

RESUMEN

BACKGROUND: Diurnal fluctuation of bile acid (BA) concentrations in the enterohepatic system of mammals has been known for a long time. Recently, BAs have been recognized as signaling molecules beyond their well-established roles in dietary lipid absorption and cholesterol homeostasis. METHODS AND RESULTS: The current study depicted diurnal variations of individual BAs detected by ultra-performance liquid chromatography/mass spectrometry (UPLC/MS) in serum and livers collected from C57BL/6 mice fed a regular chow or a chow containing cholestyramine (resin). Circadian rhythms of mRNA of vital BA-related nuclear receptors, enzymes, and transporters in livers and ilea were determined in control- and resin-fed mice, as well as in farnesoid X receptor (FXR) null mice. The circadian profiles of BAs showed enhanced bacterial dehydroxylation during the fasting phase and efficient hepatic reconjugation of BAs in the fed phase. The resin removed more than 90% of BAs with ß-hydroxy groups, such as muricholic acids and ursodeoxycholic acid, from serum and livers, but did not exert as significant influence on CA and CDCA in both compartments. Both resin-fed and FXR-null mouse models indicate that BAs regulate their own biosynthesis through the FXR-regulated ileal fibroblast growth factor 15. BA flux also influences the daily mRNA levels of multiple BA transporters. CONCLUSION: BA concentration and composition exhibit circadian variations in mouse liver and serum, which influences the circadian rhythms of BA metabolizing genes in liver and ileum. The diurnal variations of BAs appear to serve as a signal that coordinates daily nutrient metabolism in mammals.


Asunto(s)
Ácidos y Sales Biliares/sangre , Ácidos y Sales Biliares/metabolismo , Proteínas Portadoras/genética , Ritmo Circadiano , Regulación Enzimológica de la Expresión Génica , Hígado/metabolismo , Glicoproteínas de Membrana/genética , Animales , Ácidos y Sales Biliares/biosíntesis , Resina de Colestiramina/farmacología , Ritmo Circadiano/efectos de los fármacos , Circulación Enterohepática/efectos de los fármacos , Eliminación de Gen , Regulación Enzimológica de la Expresión Génica/efectos de los fármacos , Hígado/efectos de los fármacos , Hígado/enzimología , Hígado/fisiología , Masculino , Ratones , Ratones Endogámicos C57BL , ARN Mensajero/genética , ARN Mensajero/metabolismo , Receptores Citoplasmáticos y Nucleares/deficiencia , Receptores Citoplasmáticos y Nucleares/genética , Receptores Citoplasmáticos y Nucleares/metabolismo , Transducción de Señal/efectos de los fármacos , Transcriptoma/efectos de los fármacos
7.
Anat Rec ; 266(4): 218-25, 2002 04 01.
Artículo en Inglés | MEDLINE | ID: mdl-11920384

RESUMEN

Osteoprotegerin (OPG) is a novel secreted member of the tumor necrosis factor (TNF) receptor superfamily that negatively regulates osteoclastogenesis. The receptor activator of the NFKB ligand (RANKL) is one of the key regulatory molecules in osteoclast formation and binds to OPG. In this study, it was suggested that OPG and RANKL are involved in alveolar bone remodeling during orthodontic tooth movement. We examined RANKL localization and osteoclast induction in periodontal tissues during experimental movement of incisors in OPG-deficient mice. To produce orthodontic force, an elastic band was inserted between the upper right and left incisors for 2 or 5 days, and the dissected maxillae were examined for cytochemical and immunocytochemical localization of tartrate-resistant acid phosphatase (TRAP), vacuolar-type H(+)-ATPase, and RANKL. Compared to wild-type OPG (+/+) littermates, TRAP-positive multinucleated cells were markedly induced in the periodontal ligament (PDL) on the compressed side and in the adjacent alveolar bone of OPG-deficient mice. These multinucleated cells exhibited intense vacuolar-type H(+)-ATPase along the ruffled border membranes. Because of accelerated osteoclastic resorption in OPG-deficient mice, alveolar bone was severely destroyed and partially perforated at 2 and 5 days after force application. In both wild-type and OPG-deficient mice, RANKL expression became stronger at 2 and 5 days after force application than before force application. There was no apparent difference in intensity of RANKL expression between OPG (+/+) littermates and OPG-deficient mice. In both wild-type and OPG-deficient mice, expression of RANKL protein was detected in osteoblasts, fibroblasts, and osteoclasts mostly located in resorption lacunae. These results suggest that during orthodontic tooth movement, RANKL and OPG in the periodontal tissues are important determinants regulating balanced alveolar bone resorption.


Asunto(s)
Glicoproteínas/deficiencia , Osteoclastos/fisiología , Periodoncio/fisiología , Receptores Citoplasmáticos y Nucleares/deficiencia , Receptores del Factor de Necrosis Tumoral/deficiencia , Técnicas de Movimiento Dental , Fosfatasa Ácida/análisis , Adenosina Trifosfato/análisis , Animales , Remodelación Ósea/fisiología , Proteínas Portadoras/análisis , Glicoproteínas/genética , Técnicas para Inmunoenzimas , Incisivo/fisiología , Isoenzimas/análisis , Glicoproteínas de Membrana/análisis , Ratones , Ratones Endogámicos , Ratones Noqueados , Osteoclastos/química , Osteoclastos/citología , Osteoprotegerina , Periodoncio/química , Periodoncio/citología , Ligando RANK , Receptor Activador del Factor Nuclear kappa-B , Receptores Citoplasmáticos y Nucleares/genética , Receptores del Factor de Necrosis Tumoral/genética , Fosfatasa Ácida Tartratorresistente
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA